Related Experiment Videos
Chronic hypnotic efficacy of estazolam
Drugs Under Experimental and Clinical Research
|January 1, 1986
Summary
Estazolam 2.0 mg effectively treats chronic insomnia by improving sleep onset and duration for up to six weeks. This hypnotic medication demonstrated significant benefits without notable withdrawal effects upon discontinuation.
Area of Science:
- Pharmacology
- Sleep Medicine
- Clinical Trials
Background:
- Chronic insomnia is a prevalent sleep disorder affecting millions.
- Polysomnography is the gold standard for diagnosing sleep disturbances.
- Estazolam is a benzodiazepine derivative used for hypnotic purposes.
Purpose of the Study:
- To evaluate the chronic hypnotic efficacy of estazolam 2.0 mg.
- To assess the impact of estazolam on sleep onset and total sleep time.
- To investigate recovery effects after estazolam discontinuation.
Main Methods:
- A double-blind, placebo-controlled study design was employed.
- Participants included adult subjects with verified insomnia.
- Estazolam 2.0 mg or placebo was administered for specified periods, with polysomnography used for sleep monitoring.
Main Results:
- Estazolam 2.0 mg significantly improved sleep onset.
- Total sleep time was significantly increased with estazolam administration.
- These improvements were sustained for up to six weeks of nightly use.
Conclusions:
- Estazolam 2.0 mg is an effective hypnotic for chronic insomnia.
- The medication shows sustained efficacy for at least six weeks.
- No consistent adverse recovery effects were observed upon discontinuation.